特别提示：包括重组人TNFRSF1B在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组人TNFRSF1B
英文名称：Recombinant Human Tumor Necrosis Factor Receptor II
产品货号：JN0473
产品规格：10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Lys288-Ser461在C端含有His标签。

TNFRSF1B质量控制：＞95%(还原性SDS-PAGE)

TNFRSF1B制剂：冻干品

TNFRSF1B保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

TNFRSF1B复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于TNFRSF1B：
Tumor necrosis factor receptor superfamily member 1B(TNFRSF1B) is expressed by the gene TNFRSF1B. The soluble form is produced from the membrane form by proteolytic processing. It can bind to TRAF2, and interacts with BMX. It can act as the receptor with high affinity for TNFSF2/TNF-alpha and approximately 5-fold lower affinity for homotrimeric TNFSF1/lymphotoxin-alpha. The TRAF1/TRAF2 complex recruits the apoptotic suppressors BIRC2 and BIRC3 to TNFRSF1B/TNFR2. This receptor mediates most of the metabolic effects of TNF-alpha.

根据您的关注的重组人TNFRSF1B，重组Tumor Necrosis Factor Receptor II，Recombinant Human Tumor Necrosis Factor Receptor II，重组人Tumor Necrosis Factor Receptor II，您可能还对以下产品有需求：



名称：重组人VEGFD(血管内皮生长因子D)(带His标签)
货号：JN0235
规格：10μg|50μg|500μg|1mg
本品由我们的哺乳动物表达系统制备，目的基因编码的Phe93-Ser201在C端含有His标签。

VEGFD质量控制：＞95%(还原性SDS-PAGE)。

VEGFD制剂：冻干品

VEGFD保存：
冻干蛋白可在-20℃长期保存，室温也可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天。
复溶后建议分装冻存在-20℃，可保存3个月，应避免反复冻融。

VEGFD复溶：
1、试剂开盖前请先离心。
2、复溶浓度应大于100 μg/ml.
3、冻干蛋白溶于ddH2O中
4、复溶后根据使用量分装保存，避免反复冻融。

关于VEGFD：
Vascular endothelial growth factor D (VEGF-D) is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family. It is highly expressed in lung, heart, small intestine and fetal lung, and at lower levels in skeletal muscle, colon, and pancreas. VEGF-D is growth factor active in angiogenesis, lymphangiogenesis and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. It may function in the formation of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. It undergoes a complex proteolytic maturation, generating multiple processed forms that bind and activate VEGFR-2 and VEGFR-3 receptors.

关注重组人TNFRSF1B，重组Tumor Necrosis Factor Receptor II，Recombinant Human Tumor Necrosis Factor Receptor II，重组人Tumor Necrosis Factor Receptor II的同时，为您推荐更多您可能感兴趣的产品：


JN0333 重组人白介素IL-11(白细胞介素11) 10μg|50μg|500μg|1mg
JN0345 重组人白介素IL-4(白细胞介素4) 10μg|50μg|500μg|1mg
JN0942 重组人SH2D1A(含SH2结构域蛋白1A) 10μg|50μg|500μg|1mg
JN1149 重组人BMPR1A(骨形成蛋白受体1A)(激活素受体样激酶3) 10μg|50μg|500μg|1mg
JN1227 重组人载脂蛋白E(ApoE) 10μg|50μg|500μg|1mg
JN1232 重组小鼠COL3A1(III型胶原蛋白α1链) 10μg|50μg|500μg|1mg
JN1485 重组人B7-H1(PD-L1) 10μg|50μg|500μg|1mg